Thérèse Croughs

Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.

Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005.

PricewaterhouseCoopers Audit SA provides accounting, auditing and consulting services. The company was founded on February 10, 1967 and is headquartered in Neuilly-sur-Seine, France.

France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.

Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris.

INVESTSUD SA (INVESTSUD) is an independent venture capital firm founded in 1983. Investsud SA is headquartered in Marche-en-Famenne, Belgium.

Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France.

Comet Traitements SA provides waste management services for ferrous and non-ferrous metals. The company is based in Chatelet, Belgium. The Belgian company was founded in 2002. Claude Bodson has been the CEO of the company since 2017.

Certi-Fed SA is an investment holding Belgian company founded in 2007. The private company is based in Brussels, Belgium.

Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France.

SFPI FPIM /PRIVATE EQUITY/ (SFPI FPIM) is the private equity division of SFPI-FPIM SA/NV, which is ultimately-owned by the state of Belgium. The firm was founded in 1994, and is headquartered in Brussels, Belgium.

Part of Biosynex SA, Prestizia SASU is a French company that provides biotechnology research and development services. The private company is based in Paris, France. Odile Prigneau has been the CEO of the company since 2013. Prestizia was acquired by Theradiag SA, a subsidiary of Biosynex SA from Truffle Capital SAS on June 27, 2012.

OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium.

PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France.

Accessia Pharma SA is a Belgian company that focuses on manufacturing products according to the needs of their clients. The company is based in Herstal, Belgium. The company provides tools and resources to help their clients benefit from economies of scale. Benjamin Boinem has been the CEO of the company since 2015.

AuXin Surgery SA develops, manufactures, and supplies combined medical devices for non-invasive surgery. The private company is based in Ottignies-Louvain-la-Neuve, Belgium. The Belgian company was founded in 2014 by Philippe Capart, Cecile Capart, Herve Capart, Carlo Zini, and Gilles Capart. The CEO is Benoît Verjans.

IRE ELiT SRL is a company based in Fleurus, Belgium that specializes in the fabrication of radiochemical and radiopharmaceutical products, as well as providing radioactivity analysis services. The Belgian company has developed a new platform called RAMSES for real-time radiological analysis. For the past 50 years, IRE has been at the forefront of innovation in healthcare and nuclear medicine services. The company was founded in 2010 and the CEO is Erich Kollegger.

Innovation Fund is a venture capital firm founded in 2015. The firm headquartered located in Schaerbeek, Belgium.

Part of PDC Line Pharma SASU, PDC Line Pharma is a Belgian company that focuses on medical needs, particularly on skin cancer, which is the most lethal form of cancer worldwide. The private company is based in Liege, Belgium, and has two drug candidates in its pipeline, one for melanoma and another for lung cancer. The company aims to address this issue by developing drug candidates that can bring positive results to patients. PDC Line Pharma was founded in 2016 by Laurent Levy and Joel Plumas, and its CEO is Eric Halioua.

Nucleis SA is a radiopharmaceutical company based in Liege, Belgium. The Belgian company proposes and manufactures Radiopharmaceutical Drugs for Diagnostic and Therapy Monitoring. Fabrice Giacomelli has been the CEO of the company since 2017.

White Fund SA invests in companies located in Belgium and possibly neighbouring regions. It targets companies operating in the medical device sector. It provides financing for early stage with an investment size ranging between €2 million and €5 million per project. Exits are targeted after 5-7 years.

Industrya SA invests in companies located in the Benelux, Germany and France. It targets companies operating in the fields of energy transition, 4.0 Industries and new materials. It provides funding for seed stage and early stage and takes minority shareholdings.

Fluxys SA is an independent energy infrastructure group based in Brussels, Belgium with 1,300 employees. The Belgian company is active in gas transmission and storage, as well as liquefied natural gas terminalling. Fluxys operates 12,000 kilometers of pipeline and liquefied natural gas terminals with a yearly regasification capacity of 29 billion cubic meters. The company's purpose is to contribute to a better society by shaping a bright energy future. Fluxys is committed to transporting hydrogen, biomethane, or any other carbon-neutral energy carrier, as well as CO2, accommodating the capture, usage, and storage of the latter. The company was founded in 2008, and the CEOs are Walter Peeraer and Pascal de Buck.

Cometsambre SA the recycling of ferrous metals is one of the COMET Group's main activities, performed through Cometsambre SA, and also forms the main axis for development and expansion. The growth of COMETSAMBRE means that they now handle a supply of almost 1 000 000 tones of scrap iron per year, making they the biggest producer of iron and steel industry materials in Belgium. The principles constantly applied in its management, expansion, commercial and operational pro-activity and technological expertise make COMETSAMBRE a leading company in the world of ferrous metal recycling. They are a serious partner, guaranteeing product quality, and respect for environmental standards-technical performance for recycling.

Part of Société Publique de la Gestion de l'Eau SA, Société Wallonne des Eaux is a water distribution company based in Verviers, Belgium. Société Wallonne des Eaux has invested €117 million in renewing its infrastructure to maintain a long-term service of quality drinking water distribution. The Belgian company provides information on water installations, pricing, and consumption control through its online customer portal. The private company was founded in 1986 and is currently led by Isabelle Jeurissen, Eric van Sevenant, and Philippe Boury.